Global Orphan Drug Pipeline Analysis

1
Global Orphan Drug Pipeline Analysis
One-Stop Shop for Business Information
2
Summary
In recent years, the pharmaceutical industry has
been experiencing a paradigm shift. While a large
pool of patients was considered as a major source
of revenue for pharma companies in the past, the
focus is now gradually shifting to small sections
of patients suffering from rare disease. In US
Europe, this pool of patients is gradually
growing and orphan drugs are becoming an
extremely attractive business proposition for the
pharmaceuticals industry. With close to 65-70
Million people in the US Europe having some
kind of rare disease complaints, the increasing
activities around the development of orphan drugs
only imply that the appropriate treatments for
unmet needs are increasing, thus increasing the
profit margins in the future. As the Asian
pharmaceutical markets are still in growth stage,
the opportunities for orphan drugs in Asia are
also immense and getting increasingly popular.
3
It is expected that by 2020, the Asian orphan
drugs market would witness steady
growth. Global Orphan Drug Pipeline Analysis
gives comprehensive insight on the various orphan
designated drugs being developed for the
treatment of rare disease. Research report covers
all the orphan designated drugs being developed
in various development phases. This report
enables pharmaceutical companies, collaborators
and other associated stake holders to identify
and analyze the available investment opportunity
in the Orphan Drug market based upon development
process.
4
Following parameters for each orphan designated
drug profile in development phase are covered in
Global Orphan Drug Pipeline Analysis research
report Drug Profile Overview Alternate
Names for Drug Active Indication Phase of
Development Mechanism of Action
5
Brand Name Patent Information Orphan
Designation by Indication, Country
Organisation Country for Clinical Trial
Owner / Originator/ Licensee/Collaborator
Administrative Route Drug Class ATC Codes
6
Table of Contents

1. Global Orphan Drugs Market Overview
2. Orphan Drug Clinical Development Phase Unknown
3. Orphan Drug Clinical Development Phase Research
4. Orphan Drug Clinical Development Phase
   Preclinical
5. Orphan Drug Clinical Drug Development Phase
   Clinical
6. Orphan Drug Clinical Development Phase Phase-I
7. Orphan Drug Clinical Development Phase
   Phase-I/II
8. Orphan Drug Clinical Development Phase Phase-II
9. Orphan Drug Clinical Development Phase
   Phase-II/III
10. Orphan Drug Clinical Development Phase Phase-III

7
Related Reports

• Market Access for Orphan Drugs assessing the
  global landscape
• Alzheimer's Pipeline Drugs Review, Alzheimer's
  Disease Drug Market Forecast - Global Analysis
• Research Report on China Osteoporosis Drug
  Market, 2013-2017
• 2014 Analysis of the European Drugs of Abuse
  Testing Market Hospitals, Commercial Labs,
  Physician Offices, Ambulatory Care Centers
• 2014 Analysis of the European Therapeutic Drug
  Monitoring (TDM) Market Hospitals, Commercial
  Labs, Physician Offices, Ambulatory Care Centers

8
Custom Research

• Incase the reports dont match your
  requirement then we can do a Custom Research for
  you. Our multifarious capabilities, cross-sector
  expertise and detailed knowledge of various
  markets, put us at a unique position to take up
  Custom Research demands of yours. We provide the
  specifications of the custom research job to a
  dedicated team comprising of researchers,
  analysts and industry experts, who have close
  experience and understanding of global markets,
  competitive landscapes, various business models,
  market shares, drivers, restraints and
  benchmarks.
• http//www.bharatbook.com/customResearch.asp

9
For More Information You Can Visit

• http//www.bharatbook.com/healthcare-market-resear
  ch-reports/global-orphan-drug-pipeline-analysis.ht
  ml

Request Sample Pages
Contact Us-Call India 91-22-27810772/73 Call
USA/Canada (Toll Free) 1-866-279-8368 For Live
Chat - http//bit.ly/19m3TU4
Follow/Like Us on-